First drugs chosen in European early licensing pilot
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has selected the first two medicines to enter its pilot adaptive licensing project, out of a total of 20 applications received from companies so far. It is considering four more as potential candidates to be included at a later stage, has rejected three as being unsuitable, and is still evaluating the remaining 11.